English (United States)

RELIEF Migraine Registry

reduce font Size enlarge font Size print content

Chronic migraine is a disabling neurological disorder. An “implantable neurostimulation system” recently obtained a CE Mark approval for using Nerve Stimulation to manage pain and disability associated with intractable chronic migraine.

The RELIEF Migraine Registry was recently launched at the Centre Hospitalier de Luxembourg (CHL) as participating center and coordinated by the Clinical and Epidemiological Investigation Center (CIEC). The registries primary objective is to evaluate the long-term safety and performance of the “implantable neurostimulation system”. Patients will be enrolled in the registry post-implant and followed for 24 months. Data will be collected at enrollment and routine care follow-up visits. To find more information on the RELIEF Migraine Registry please visit our website www.luxclin.lu (all studies).

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.